Cinemark (CNK) Q2 2024 earnings summary

Executive summary

• Outperformed industry recovery in both domestic and international markets, gaining market share and delivering strong financial results in FY23 and Q2 2024, despite year-over-year declines due to lower attendance and fewer blockbuster releases.

• Maintained a high-quality asset base with investments in guest experience, premium formats, and food & beverage, supporting resilience and optimism for continued growth.

• Strategic initiatives and operational execution led to market share gains and robust box office results, with record-setting performances in select regions.

• Continued to strengthen the balance sheet through debt reduction, refinancing, and disciplined capital allocation.

• Remains optimistic about long-term recovery, supported by a robust film slate and strong consumer demand.

Financial highlights

• Q2 2024 revenue was $734.2 million, with adjusted EBITDA of $142.1 million (19.4% margin), and net income of $46–47 million; diluted EPS was $0.32.

• FY23 revenue grew 25% to $3.1 billion, with adjusted EBITDA of $594 million (19.4% margin); FY23 free cash flow was $295 million.

• Six-month 2024 revenue was $1.31 billion, with net income of $71.9 million and free cash flow of $115–161 million.

• Attendance in Q2 2024 was 50 million globally, with U.S. attendance at 29.1 million and international at 20.9 million.

• Domestic concession per cap hit a record $7.95, with average ticket price at $7.32 and concession revenue per patron at $5.86.

Outlook and guidance

• Anticipates content volume recovery in 2025–2026, with potential to reach or exceed pre-pandemic levels.

• Expects modest growth in average ticket prices for 2024, with ongoing inflationary pressures and cost controls.

• Management remains optimistic about box office performance and sufficient liquidity to meet obligations.